In the article by Stadler et al, entitled, “Prospective Randomized Multicenter Clinical Trial on the Use of Interferon α-2a Plus Acitretin Versus Interferon α-2a Plus PUVA in Patients With Cutaneous T-Cell Lymphoma (CTCL) Stages I and II,” which appeared in the November 15, 1998 issue (Vol 92, No. 10, pp 3578-3581), a correction should be noted. The author list was incorrect and should read as follows: R. Stadler, H.G. Otte, B.M. Henz, P. Kühl, T. Zwingers, Ch. Willers, and W. Sterry.
